L-carnitine supplementation in non-alcoholic fatty liver disease: A systematic review and meta-analysis

doi:10.13105/wjma.v8.i1.4

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (11505)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-1) series.

Item

Count

PDF

442

WORD

170

HTML

7425

Figures (1-5)

390

Tables (1-1)

416

Sum=8843

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1051

Download

1611

Sum=2662

Feb 28, 2020 (publication date) through Dec 26, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Meta-Analysis

ISSN

2308-3840

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

World J Meta-Anal. Feb 28, 2020; 8(1): 4-14
Published online Feb 28, 2020. doi: 10.13105/wjma.v8.i1.4

Full Size Figure Download Figure

Figure 2 Methodological quality assessment according to the Cochrane risk of bias tool.

Citation: Thiagarajan P, Chalmers J, Ban L, Grindlay D, Aithal GP. L-carnitine supplementation in non-alcoholic fatty liver disease: A systematic review and meta-analysis. World J Meta-Anal 2020; 8(1): 4-14
URL: https://www.wjgnet.com/2308-3840/full/v8/i1/4.htm
DOI: https://dx.doi.org/10.13105/wjma.v8.i1.4